KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Change in Receivables (2016 - 2025)

CareDx's Change in Receivables history spans 13 years, with the latest figure at -$5.3 million for Q4 2025.

  • For Q4 2025, Change in Receivables fell 193.31% year-over-year to -$5.3 million; the TTM value through Dec 2025 reached -$22.5 million, down 263.9%, while the annual FY2025 figure was -$22.5 million, 263.9% down from the prior year.
  • Change in Receivables for Q4 2025 was -$5.3 million at CareDx, up from -$19.6 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $9.2 million in Q1 2024 and bottomed at -$19.6 million in Q3 2025.
  • The 5-year median for Change in Receivables is $309500.0 (2022), against an average of $314000.0.
  • The largest annual shift saw Change in Receivables soared 473.19% in 2021 before it tumbled 5800.0% in 2025.
  • A 5-year view of Change in Receivables shows it stood at $2.8 million in 2021, then crashed by 247.32% to -$4.2 million in 2022, then surged by 84.08% to -$665000.0 in 2023, then plummeted by 172.03% to -$1.8 million in 2024, then plummeted by 193.31% to -$5.3 million in 2025.
  • Per Business Quant, the three most recent readings for CDNA's Change in Receivables are -$5.3 million (Q4 2025), -$19.6 million (Q3 2025), and -$4.3 million (Q2 2025).